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Background: Exposure of the airways to carbonaceous nanoparticles can contribute to the development of
immune diseases both via the aggravation of the allergic immune response in sensitized individuals and by
adjuvant mechanisms during the sensitization against allergens. The cellular and molecular mechanisms involved in
these adverse pathways are not completely understood. We recently described that the reduction of carbon
nanoparticle-induced lung inflammation by the application of the compatible solute ectoine reduced the aggravation
of the allergic response in an animal system. In the current study we investigated the influence of carbon nanoparticles
on the sensitization of animals to ovalbumin via the airways. Ectoine was used as a preventive strategy against
nanoparticle-induced neutrophilic lung inflammation.
Methods: Balb/c mice were repetitively exposed to the antigen ovalbumin after induction of airway inflammation by
carbon nanoparticles, either in the presence or in the absence of ectoine. Allergic sensitization was monitored by
measurement of immunoglobulin levels and immune responses in lung and lung draining lymph nodes after
challenge. Furthermore the role of dendritic cells in the effect of carbon nanoparticles was studied in vivo in the
lymph nodes but also in vitro using bone marrow derived dendritic cells.
Results: Animals exposed to antigen in the presence of carbon nanoparticles showed increased effects with
respect to ovalbumin sensitization, to the allergic airway inflammation after challenge, and to the specific TH2
response in the lymph nodes. The presence of ectoine during the sensitization significantly reduced these
parameters. The number of antigen-loaded dendritic cells in the draining lymph nodes was identified as a possible
cause for the adjuvant effect of the nanoparticles. In vitro assays indicate that the direct interaction of the particles with
dendritic cells is not able to trigger CCR7 expression, while this endpoint is achieved by lung lavage fluid from
nanoparticle-exposed animals.
Conclusions: Using the intervention strategy of applying ectoine into the airways of animals we were able to
demonstrate the relevance of neutrophilic lung inflammation for the adjuvant effect of carbon nanoparticles on
allergic sensitization.
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Epidemiological studies demonstrated correlations be-
tween exposure to particulate air pollution and the inci-
dence and severity of allergic diseases of the airways [1].
Besides sources like environmental tobacco smoke, ul-
trafine particles from traffic related air pollution have
been suggested as modulators of allergic reactions lead-
ing to adverse health effects [2, 3]. With the increasing
use of nanomaterials in daily life products, human airways
might be exposed to inhalable poorly soluble nanoparticles
including combustion derived carbon nanoparticles from
toners and printers [4]. Carbonaceous nanoparticles in the
airways can contribute to both, the exacerbation of the
immune response in antigen-exposed sensitized individ-
uals, but also the allergic sensitization against daily life
antigens [5, 6].
Mechanistic animal studies demonstrated that the ex-
posure to different kinds of allergens in the presence of
diesel exhaust particles (DEP) leads to a potentiation of
the antigen-specific sensitization [7, 8]. Comparing chem-
ically different kinds of diesel samples revealed that the
amount of organic carbon compounds contaminating the
elementary carbonaceous core significantly modulates the
strength of this adjuvant effect on the sensitization against
antigens [9]. A number of studies however also demon-
strate that ultrafine engineered carbon nanoparticles
(CNP) which contain only traces of organic carbon en-
hance the sensitization [10]. In these studies, the increase
of antigen-specific IgE was associated with lung inflamma-
tion induced by CNP when applied to the airways of the
animals [11]. The comparison of chemically similar par-
ticle samples of different size classes demonstrate an in-
creasing effectivity associated with the decrease in primary
particle size [12, 13]. The influence of spark-generated car-
bon nanoparticles on immune reactions of the airways has
been shown at the level of the immune response after
challenging sensitized mice [14]. In a recent study this ex-
acerbating effect was investigated in asthmatic volunteers
who were exposed to CNP or filtered air in a cross over
design prior to allergen challenge. Interestingly, a delayed
effect of CNP on the strength of allergic airway inflamma-
tion was observed [15]. In a murine model, the occurrence
of markers of oxidative stress was associated with the ex-
acerbation of the allergic lung inflammation by the inhaled
CNP [16]. The enhancement of the antioxidant capacity of
the airways by adding N-acetyl cysteine led to a significant
reduction of the exacerbating effect of the inhaled CNP.
Taken together, these studies indicate that the enhanced
inflammatory response of the airways as well as the oxida-
tive burst in response to the inhalation of ultrafine parti-
cles might be a central mechanism of adverse effects of
inhaled nanoparticles on immune diseases of the airways.
Strategies which reduce airway inflammation should
therefore be able to prevent both the exacerbation ofthe immune response in sensitized individuals but also
the adjuvant effect during allergic sensitization.
We recently described the potential of a group of sub-
stances, named compatible solutes, to prevent CNP-
induced pro-inflammatory reactions in the airways of
exposed animals [17]. These substances can be isolated
from extremophilic bacteria which produce them in
order to stabilize cellular functions under extreme life
conditions like heat or osmotic stress. Based on the
principle of preferential exclusion, compatible solutes
stabilize macromolecules like membrane lipids and pro-
teins [18–20]. In lung epithelial cells, we were able to
demonstrate that CNP-triggered non-canonical activa-
tion of EGFR signalling is prevented in the presence of
ectoine due to a stabilization of the receptor in the lipid
raft signalling compartment of the cells [21]. Addressing
inflammatory kinetics in the airways in vivo, we ob-
served similar effects of CNP and of ectoine on cell
stress reactions executed on neutrophilic granulocytes
(PMN). CNP contribute to the aggravation of the inflam-
mation by suppressing natural apoptosis rates via mem-
brane dependent signalling in both human peripheral
PMN and in vivo in exposed rat lungs [22]. The prevent-
ive application of ectoine restored apoptosis rates and
led to an accelerated resolution of the neutrophilic lung
inflammation. As a proof of the biophysical principle of
preferential exclusion, we observed that besides ectoine
which is isolated from halophilic bacteria, firoin a sub-
stance produced by thermophilic bacteria, is also able to
prevent the adverse cell stress reactions in lung epithe-
lium and in neutrophils [23].
The possibility to prevent CNP-induced neutrophilic
lung inflammation directly at the level of PMNs offers the
possibility to test whether this early reaction of the airways
contributes to the development of responses of the adap-
tive immune system after allergen challenge. In a recent
report we described that the aggravation which is mediated
by CNP applied during antigen challenge in sensitized mice
can be significantly reduced in the presence of ectoine [24].
The current study aimed to investigate how the adjuvant
effect of CNP during sensitization against ovalbumin is
mediated and whether it is reduced when neutrophilic lung
inflammation is attenuated by the application of the com-
patible solute ectoine. For that purpose, we chose the ex-
perimental system of pharyngeal aspiration in which the
strength of neutrophilic lung inflammation can be strictly
controlled by ectoine. Sensitization via the lower airways
and adaptive immune responses after sensitization and
challenge were investigated using a mouse model of aller-
gic airway disease in Balb/c mice. In order to separate ef-
fects of neutrophilic lung inflammation from direct effects
of particles and ectoine on antigen presenting cells, mech-
anistic studies employing ex vivo differentiated dendritic
cells were performed.
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As a pre-requisite for in vivo and in vitro investigations with
CNP, particle suspensions were analysed for their physico
chemical characteristics. CNP (14 nm, primary diameter)
are known to form agglomerates in physiological aqueous
solution. Characteristics of the particle suspensions are given
in the supplementary data (Additional file 1: Figure S1 and
Table S1). In earlier studies we applied such agglomerated
nanoparticles in vitro and in vivo and observed size or
surface specific effects when compared to bigger non-nano
particles which showed very similar agglomerate size
distributions [21].
In a pilot animal study, the effect of ectoine on the
lung inflammation induced by the pharyngeal aspiration
of 2.5 mg/kg CNP was investigated after 12, 24, and
48 h (Fig. 1a). A mild inflammatory increase in total cells
numbers and specifically in neutrophils was observed
12 h after single application of CNP in the broncho-
alveolar lavage (BAL) as compared to BAL of control
mice (Fig. 1b). Following the kinetics of the lung inflam-
mation, at later time points decreasing numbers of neu-
trophils were observed, while the number of clearing
macrophages was increased. Accordingly, the application
of 1 mM ectoine together with the particles led to a re-
duction of total cell numbers due to the significantly
lower neutrophil numbers. Ectoine had no significant ef-
fect on the number of macrophages at all time points.
This effect was nicely reflected at the level of the neutro-
phil recruiting chemokine CXCL1 (homologue to human
IL-8). In earlier studies we demonstrated that the effect
on the reduction of neutrophilic lung inflammation is
not due to changes in particle properties but is caused
by the effect of ectoine on membrane dependent signal-
ling processes both in lung epithelial cells and in neutro-
phils [17]. As previously published, ectoine also reduced
the amount of cytokines like IL-5 and IL-6 in BAL of ex-
posed mice after 12 h [24]. The data demonstrate that
neutrophilic lung inflammation induced by pharyngeal
aspiration of CNP can be modulated by the application
of ectoine. This system enabled us to study the influence
of the inflammatory reaction on allergic sensitization via
the lower airways.
Therefore, the effect of CNP on allergic sensitization
was tested in a model of allergic airway inflammation
in vivo (Fig. 2a). Lung inflammation was induced by the
application of 2.5 mg/kg CNP in the presence or absence
of 1 mM ectoine. At the peak of the inflammatory re-
sponse, after 12 h, OVA was applied to the lower airways
also by pharyngeal aspiration. After a recovery period of
two days each, the procedure was repeated three times.
In order to induce an allergic immune response, animals
were challenged in an exposure chamber on three consecu-
tive days. As described by de Haar et al. [12] sensitization
via the airways in Balb/c mice leads to increased allergenspecific IgE levels. We therefore monitored OVA specific
IgE levels in the serum of the animals pre and post chal-
lenge (Fig. 2b). While only non-significant trends in OVA
specific immunoglobulin were observed prior to the chal-
lenge, a significant increase of this parameter in CNP-
exposed animals was observed after boosting. This effect
was significantly lower when ectoine was applied to the air-
ways during the sensitization phase, indicating a preventive
effect of ectoine on the adjuvant effect of CNP. Similar
effects were observed at the level of antigen-induced lung
inflammation after challenge (Fig. 2c). BAL cells were iden-
tified by flow cytometry after staining with GR-1 and
CD11c as described elsewhere [11]. OVA inhalation in-
creased BAL cell numbers only in animals which were sen-
sitized in the presence of CNP while animals sensitized in
the presence of CNP and ectoine had significantly less in-
flammatory cells in the lung. This attenuation is mainly due
to the significant reduction of neutrophils which is again
reflected by the CXCL1 levels in BAL (Fig. 2d). Interest-
ingly, predominantly the neutrophilic inflammation is
affected by ectoine, the enhanced amount of eosinophils
and lymphocytes in BAL, which might be induced by the
induction of the allergic reaction is rather unaltered. As the
inflammatory response is still dominated by neutrophil
numbers, the effect on the other cell types might not be
visible in the statistical analyses.
In order to verify the effect of CNP on the sensitization
against OVA and to further investigate the possible effects
of ectoine on this process, we studied the adaptive im-
mune reactions in the peribronchial lymph nodes of the
animals at day 35 by flow cytometry (Fig. 3a). Total cell
numbers appeared to reflect the sensitization status of the
animals. A significant increase in all tested cell types (B
cells, CD8+ T cells, and CD4+ T cells) was observed in ani-
mals which were sensitized in the presence of CNP. Num-
bers of all cell types were lower in the animals in which
ectoine was present in the initial experimental phase. As
an additional readout for differences in the immune status
of the animals, cultured lymph node cells were re-
stimulated with OVA and the TH2 cytokines IL-4 (Fig. 3b)
and IL-13 (Fig. 3c) were determined in the supernatants.
Both cytokines were significantly elevated only in cell cul-
tures from animals sensitized in the presence of CNP. A
statistically significant reduction was observed for the IL-
13 release in the samples from CNP plus ectoine animals,
whereas IL-4 levels were not altered significantly by
ectoine.
The data presented so far demonstrate a strong adju-
vant effect of CNP on the process of sensitization against
the allergen OVA via the airways. The reduction of the
neutrophilic lung inflammation by ectoine application
during sensitization suggests that this adjuvant effect is
driven by the lung inflammation. Since the immune re-
sponse in the lung draining lymph nodes is also affected
Fig. 1 Ectoine application reduces neutrophilic lung inflammation induced by CNP in Balb/c mice. a Experimental design, animals (n = 5) were
exposed to PBS (control), 2.5 mg/kg CNP, or 2.5 mg/kg CNP with 1 mM ectoine (E) and subsequently sacrificed at the indicate time points.
b Differential cell numbers in BAL (means, SEM). c CXCL1 levels in BAL. * significant differences were observed in total cell numbers, neutrophil
numbers and CXCL1 levels (p < 0.05, Mann Whitney U-test)
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Fig. 2 (See legend on next page.)
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Fig. 2 CNP exposure during sensitization leads to enhanced immune responses which can be attenuated by ectoine. a Experimental design, for
sensitization, animals (n = 8) were treated with PBS, CNP, and CNP+ E as described in Fig. 1. Additionally, 12 h after this treatment animals received
20 μg OVA. At day 21 serum was collected (S). After challenge (1 % OVA in PBS, 30 min) on three consecutive days (d32 – d34), animals were sacrificed
and BAL, blood and lymph nodes were collected. b OVA-specific IgE prior to and after challenge. c Differential cell counts (representative plots and
means, SEM) after challenge significance bar indicates differences in total cell numbers and neutrophil numbers. d CXCL1 levels in BAL after challenge.
*p < 0.05, Mann Whitney U-test
Kroker et al. Particle and Fibre Toxicology  (2015) 12:20 Page 6 of 12by the exposure to CNP, it could be possible that CNP
also directly interact with antigen presenting cells and
trigger an immune response besides their capacity to in-
duce a neutrophilic inflammation in the lung. This hy-
pothesis is supported by the finding that CD4+ cell
proliferation is enhanced in peribronchial lymph nodes
after CNP application to the airways in a concentration
which appeared not to induce accelerated neutrophil
numbers in BAL [25]. Additional data of the same study
suggest that the number of antigen presenting dendritic
cells is increased by the particle application. We there-
fore aimed to investigate the role of antigen presenting
cells after CNP and ectoine application. In an additional
animal experiment, the effects of CNP and ectoine on
macrophages and dendritic cells, which are identified as
the cell types which transport antigen from the airways
to the lymph nodes [26, 27], were investigated (Fig. 4).
At the peak of neutrophilic inflammation the fluorescently-
labelled antigen (OVA-Alexa Fluor 488) was applied to the
airways via pharyngeal aspiration in order to track migrat-
ing cells from the lung to the lymph nodes. In order to
control for effects of labelled OVA, an additional PBS
group without OVA was employed. After 36 h, lung in-
flammation was determined in BAL and peribronchial
lymph nodes were analysed for the presence of antigen car-
rying cells. Also under these experimental conditions CNP
led to an enhanced accumulation of neutrophils in the
BAL, while there was an attenuated neutrophil influx after
ectoine application (Fig. 4b). This effect was not observed
at the level of total lymph node cell numbers (Fig. 4c).
Among the dendritic cells (MHCII+/CD11c+) present in
the lymph node, an increased number of OVA-488+ cells
was observed when the antigen was applied during an on-
going CNP-triggered inflammation (Fig. 4d). This effect
was significantly reduced in the presence of ectoine. Only a
very low percentage of macrophages (MHCII+/F4/80+) was
shown to be OVA-488 positive and no effect of the ectoine
treatment was observed for this cell type (Fig. 4e). Thus,
CNP seem to enhance the migration of antigen loaded
dendritic cells to the draining lymph nodes and ectoine
appears to prevent this effect either via direct action on
dendritic cells or via the suppression of the neutrophilic
inflammation.
To address the question whether these effects are medi-
ated by the particles themselves or rather by factors re-
leased during airway inflammation, bone marrow deriveddendritic cells were exposed in vitro to CNP and to cell
free BAL fluids from exposed and control animals (Fig. 5).
The cells were tested for the expression of the chemokine
receptor CCR7 which is crucial for migration of antigen
presenting cells from the periphery to draining lymph
nodes [28]. As expected, lipopolysaccharide (LPS) as a
positive control enhanced the number of CCR7 positive
dendritic cells. This effect was not influenced in the pres-
ence of ectoine. Incubating the cells with different doses
of CNP suspensions did not lead to an increase of CCR7
positive cells (Fig. 5a). At least under these conditions the
nanoparticles had no effect on the dendritic cells. How-
ever, treating the cells with lavage fluids, devoid of cells
and particles, from animals which had been exposed to
CNP for 12 h revealed very clear results (Fig. 5b). A sig-
nificant increase in CCR7 positive cells was observed after
treatment with the lavage from CNP alone treated ani-
mals. This response was significantly lower in samples
incubated with lavage from CNP plus ectoine-treated ani-
mals. The induction of CCR7, however, was not signifi-
cantly reduced when ectoine was added to the dendritic
cell cultures in vitro as an intervention strategy against the
effects of lavage fluid from CNP-alone animals. Other stud-
ies have shown that CNP in contrast to ambient particles
do not induce the activation of dendritic cells [29]. Similar
results were obtained when we tested bone marrow de-
rived dendritic cells for the expression of CD86 after treat-
ment with CNP and lavage fluid (data not shown).
Conclusions
Taken together, the data of this study demonstrate the
importance of enhanced neutrophilic lung inflammation
induced by CNP during allergic sensitization as a pro-
moter of allergy. This is demonstrated at the level of
antigen-specific IgE, challenge-induced lung inflamma-
tion, and TH2 specific changes in the draining lymph
nodes. As a possible cause for these effects, the en-
hanced migration rate of antigen presenting dendritic
cells to the lymph node in response to the ongoing
inflammation is indicated. The intervention approach
using ectoine which moderately but specifically prevents
neutrophilic lung inflammation induced by CNP demon-
strates the causal connection of particle-induced inflam-
mation and the aggravation of the allergic reaction in
this model. This approach, therefore, also offers the possi-
bility to interfere with environmentally-induced immune
Fig. 3 Changes in lymph node responses after challenge. Lymph nodes from the animals (Fig. 2) were analysed for adaptive immune responses.
a Total cell numbers in peribronchial lymph nodes (representative plots and means, SEM). b IL-4 release in re-stimulated lymph node cells. c IL-13
release in re-stimulated lymph node cells. *p < 0.05, Mann Whitney U-test
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Fig. 4 Ectoine application reduces the frequency of antigen loaded dendritic cells in lymph nodes. a Animals (n = 3 in control groups, n = 8 in
exposure groups) were exposed to 50 μg Alexa Fluor 488-labelled OVA 12 h after the application of PBS (control), CNP, or CNP + E. In order to
control for effects of labelled OVA, an additional PBS group without OVA was employed. b BAL cell numbers (means, SEM) 36 h after initial treatment.
c Total lymph node cells. d Percentage of OVA-488 positive dendritic cells (MHCII+, CD11c+). e. Percentage of OVA-488 positive macrophages (MHCII+,
F4/80+). *significant differences were observed in total cell numbers, neutrophil numbers, and percentage of OVA-488 positive dendritic cells (p < 0.05,
Mann Whitney U-test)
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compatible solutes have been tested to be highly compat-
ible to mammals. First human studies describing the feasi-
bility and efficacy of ectoine application in upper airways
and on the skin suggest to test such compounds as a
preventive strategy against adverse health effects in the
airways induced by air pollution [30, 31]. Such a strat-
egy might be of relevance for pre-disposed individualsparticularly in situations in which exposure of the air-
ways cannot be avoided. This approach is not only rele-
vant for the prevention of environmentally induced
effects on the immune system, since engineered nano-
particles have also been described to aggravate airway
responses in experimentally induced asthma [32, 33].
Together with the finding that ectoine also reduces the
particle-dependent aggravation of the allergic immune
Fig. 5 Effects of CNP and lavage fluid on bone marrow derived dendritic cells. Dendritic cells derived from Balb/c mice (n = 7) were exposed to
the indicated doses of CNP (a) or lavage fluid (b) from exposed animals. c Representative histograms determining CCR7+ cells. *significantly
different from PBS alone, # significantly different from cells treated with BAL from CNP-exposed animals. (p < 0.05, ANOVA with post hoc testing)
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stance in humans to prevent particle induced adverse
effects on adaptive immune reactions of the airways.
Methods
Particle suspensions
Carbon nanoparticles (CNP, Printex 90) were obtained
from Degussa (Essen, Germany). Stock suspensions (1 mg/
ml) of particles were prepared in phosphate buffered saline
(PBS) as vehicle by sonication for 60 min. Particles and
particle suspensions were characterized as described in the
supplementary.
Application via pharyngeal aspiration and
bronchoalveolar lavage
Female Balb/cJRj mice (8 weeks old, Janvier, France)
were treated with particle suspensions (2.5 mg/kg body-
weight) with or without 1 mM ectoine (Sigma-Aldrich
Chemie, Deisenhofen, Germany) or PBS as control solution
via pharyngeal aspiration with a volume of 50 μl, under
inhalation anaesthesia (isoflurane, 5 % in synthetic air,
2 min). Animals were sensitized by repetitive pharyngeal
aspiration with a volume of 50 μl of 1 mg/ml Grade VI
Ovalbumin (OVA) (Sigma-Aldrich Chemie, Deisenhofen,
Germany) dissolved in PBS. At the indicated time points,
mice were challenged by aerosol inhalation (1 % OVA
in PBS) for 30 min using a Pari-Boy Nebuliser (Pari,
Starnberg, Germany). For labelling of antigen transporting
cells, 50 μl of 1 mg/ml Ovalbumin, Alexa Fluor 488 conju-
gate (OVA-488) (Invitrogen, Carlsbad, CA, USA) was ap-
plied via pharyngeal aspiration. Animals were sacrificed by
exsanguinations under deep anaesthesia after the indicated
exposure times. Bronchoalveolar lavage (BAL) was taken
using 4 × 1 ml PBS. The determination of inflammatory
cells in BAL by flow cytometry was performed according
to the method described by de Haar and colleagues, stain-
ing for GR-1 and CD11c [11]. The validity of this method
was verified by additional staining procedures for neutro-
phils (GR-1, CD11b) and macrophages (F4/80, CD11b),
for selected samples. All animal experiments were per-
formed after relevant permission according to German
animal protection laws.
Serum collection
Blood was drawn from mice on days 21 and 35 by facial
vein puncture. Serum was stored at −80 °C until meas-
urement of OVA-specific IgE antibodies by ELISA (MD
bioproducts, St Paul, MN) according to the manufac-
turer’s instructions.
Lavage parameters
BAL-cells were isolated and stained for flow cytometry.
Cell free lavage fluids were subjected to solid-phase
ELISA in order to determine CXCL1, IL-4 and IL-13(R&D systems, Minneapolis, MN) according to the man-
ufacturer’s instructions.
Peribronchial lymph node analysis
Peribronchial lymph nodes were isolated immediately
after BAL. After 15 min digestion with 1 mg/ml Collage-
nase D and 300 U/ml DNase I (both Roche, Mannheim,
Germany) in PBS at 37 °C single-cell suspensions were
made by using a 100 μm cell strainer (BD Bioscience,
Franklyn Lake, NJ, USA). Cell suspensions were incu-
bated for 10 min with red blood cell lysis buffer at 4 C.
Then cells were counted and stained for flow cytometry
using specific antibodies. Cell suspension were cultured
in RPMI-1640 medium with 10 % FCS, 1 % L-Glutamine
2 % Pen/Strep (all obtained from Sigma Aldrich) in round
bottom 96-well plate (2 × 105 cells per animal/well) and
re-stimulated with 100 mg/ml OVA for 4 days at 37 °C,
5 % CO2. Levels of IL-4 and IL-13 in culture supernatants
were measured by ELISA (R&D systems, Minneapolis,
MN) according to the manufacturer’s protocol.
Flow cytometry
Flow cytometry was performed with a FACScanto II Flow
Cytometer (BD Bioscience, BD Bioscience, Franklyn Lake,
NJ, USA) and analysed with FlowJo 7.6.5. Fluorescently la-
belled CD11c (N418), GR-1 (RB6-8C5), MHCII (M5/
144.15.2), CD4 (GK1.5), CD8b (H35-17.2), CD19 (MB19-
1), CCR7 (4B12), F4/80 (BM8) and biotin anti-APC
(APC003) were used in various combinations. Antibodies
used were from BioLegend (San Diego, CA, USA), except
for CD19 (eBioscience, San Diego, CA, USA), CD4 and
CD8 (BD Pharmingen). Dendritic cells and macrophages
loaded with OVA-488 were also detected by using flow
cytometry.
In vitro bone marrow-derived dendritic cell exposures
Bone marrow–derived dendritic cells (BMDCs) were
cultured from bone marrow by using recombinant mur-
ine granulocyte-macrophage colony-stimulating factor
(rGM-CSF) (PreproTech, Hamburg, Germany). On day
6, cells were harvested and cell purity was analysed by
flow cytometry. Cells had an average purity of 70 %. A
stock solution/suspension of CNP or lipopolysaccharides
(LPS, Escherichia coli 0111:B4; Sigma-Aldrich) was pre-
pared in PBS. Cells were exposed then for 18 h to CNP
(0, 3; 3; 30 mg/ml) with or without 1 mM ectoine, LPS
(100 ng/ml) with or without 1 mM ectoine, PBS or
ectoine alone, cell free BAL obtained from animals
which were treated 12 h with CNP alone or in combin-
ation with 1 mM ectoine, and cell free BAL obtained
from animals which were treated with CNP alone plus
1 mM ectoine in PBS in vitro. Cell viability was tested
by trypan blue (Sigma Aldrich) exclusion test. BMDCs
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sion of CCR7.
Statistical analyses
Statistical calculations were performed using IBM SPSS
statistics 22. Significant values were calculated either by
ANOVA analyses with Tukey’s HSD post hoc testing or by
comparison of individual groups by Mann–Whitney U-
test. Mean values with standard errors are given. Power
calculations for the design of animal experiments were
performed using G*Power version 3.1.5 (University of Kiel,
Germany). Graphs display means and standard errors.
Additional file
Additional file 1: Figure S1. Primary physical characteristics of CNP
determined as suspension in H2O. A. Transmission elecron micrograph. B.
Agglomerate size distribution. Table S1. Physical charcteristics of CNP
suspension in PBS.
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